down arrow

Diamyd Medical AB

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0005162880
SEK
9.62
-0.66 (-6.42%)

Dec 05

OME

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Cantargia AB
Oncopeptides AB
Calliditas Therapeutics AB
Xbrane Biopharma AB
Egetis Therapeutics AB
Hansa Biopharma AB
Vicore Pharma Holding AB
Xspray Pharma AB
Diamyd Medical AB
Infant Bacterial Therapeutics AB
FluoGuide A/S
Why is Diamyd Medical AB ?
Icon
Unrated Stock - No Analysis Available
stock-recommendationReal-Time Research Report
Verdict Report
Icon
No Data Found
Is Diamyd Medical AB for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Diamyd Medical AB
-100.0%
-0.54
57.75%
OMX Stockholm 30
8.45%
0.44
18.11%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
-4.61%
EBIT Growth (5y)
-283.27%
EBIT to Interest (avg)
-73.15
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.84
Sales to Capital Employed (avg)
0.00
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
11.49%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
5.45
EV to EBIT
-6.95
EV to EBITDA
-7.20
EV to Capital Employed
27.04
EV to Sales
1294.22
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-389.22%
ROE (Latest)
-60.45%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
Bullish
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
No Trend
OBV
Mildly Bullish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

6What is working for the Company
NET PROFIT(HY)

Higher at SEK -88.24 MM

RAW MATERIAL COST(Y)

Fallen by -100% (YoY

CASH AND EQV(HY)

Highest at SEK 423.01 MM

DEBT-EQUITY RATIO (HY)

Lowest at -84.3 %

-16What is not working for the Company
OPERATING CASH FLOW(Y)

Lowest at SEK -162.89 MM

INTEREST(HY)

At SEK 1.07 MM has Grown at 117.92%

NET PROFIT(HY)

At SEK -88.24 MM has Grown at -27.29%

DEBTORS TURNOVER RATIO(HY)

Lowest at 0.03%

OPERATING PROFIT(Q)

Lowest at SEK -47.52 MM

Here's what is working for Diamyd Medical AB
Net Profit
Higher at SEK -88.24 MM
than preceding 12 month period ended May 2025
MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (SEK MM)

Cash and Eqv
Highest at SEK 423.01 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Debt-Equity Ratio
Lowest at -84.3 %
in the last five Semi-Annual periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Raw Material Cost
Fallen by -100% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Diamyd Medical AB
Interest
At SEK 1.07 MM has Grown at 117.92%
over previous Semi-Annual period
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (SEK MM)

Operating Cash Flow
Lowest at SEK -162.89 MM and Fallen
In each year in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (SEK MM)

Net Profit
At SEK -88.24 MM has Grown at -27.29%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is negative

Net Profit (SEK MM)

Debtors Turnover Ratio
Lowest at 0.03% and Fallen
In each half year in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Operating Profit
Lowest at SEK -47.52 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (SEK MM)

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."